Effect of Pursed-Lip Breathing on Physiological Parameters and Discharge Readiness in Children With Pneumonia
PLB-PEDPNEU
The Effect of Pursed-Lip Breathing on Physiological Parameters and Discharge Readiness in Children Diagnosed With Pneumonia: A Randomized Controlled Study
2 other identifiers
interventional
66
1 country
1
Brief Summary
This study aims to evaluate the effects of Pursed-Lip Breathing (PLB) exercises on physiological parameters (such as respiratory rate, heart rate, and oxygen saturation) and discharge readiness in children diagnosed with pneumonia. The study is designed as a randomized controlled trial involving pediatric patients between the ages of 3 and 4. The intervention includes guided PLB exercises performed twice daily for three consecutive days. Data will be collected before and after each session to assess changes in physiological measures and readiness for hospital discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2025
CompletedFirst Posted
Study publicly available on registry
August 6, 2025
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedOctober 6, 2025
October 1, 2025
3 months
July 9, 2025
October 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Respiratory Rate
Respiratory rate will be measured before and after each PLB session to evaluate the intervention's effect on pulmonary function.
Before and after each PLB session over a 3-day intervention period
Change in Heart Rate
Heart rate will be recorded before and after each PLB session to assess changes in cardiovascular response.
Before and after each PLB session over a 3-day intervention period
Change in Oxygen Saturation (SpO₂)
Peripheral oxygen saturation (SpO₂) will be evaluated before and after each PLB session to determine its impact on oxygenation.
Before and after each PLB session over a 3-day intervention period
Secondary Outcomes (1)
Change in Pediatric Readiness for Hospital Discharge Scale - Parent Form (Ped-RHDS) Scores
Day 1 (morning) and Day 3 (evening)
Study Arms (2)
Control Group
NO INTERVENTIONChildren aged 3-4 years diagnosed with pneumonia will receive only standard hospital care. No additional respiratory exercise will be applied. Physiological parameters will be measured at the same intervals as the intervention group for comparison.
PLB Intervention Group
EXPERIMENTALChildren aged 3-4 years diagnosed with pneumonia will receive Pursed-Lip Breathing (PLB) exercises under nurse supervision, twice daily for three consecutive days. PLB will be performed using playful methods with a toy (e.g., saxophone ball). Respiratory rate, heart rate, and oxygen saturation will be measured before and after each session.
Interventions
Children in the intervention group will receive Pursed-Lip Breathing exercises twice daily for three days under nurse supervision. Exercises will be applied using playful techniques with a toy (e.g., saxophone ball). Physiological parameters will be measured before and after each session.
Eligibility Criteria
You may qualify if:
- Children aged 3 to 4 years
- Diagnosed with community-acquired pneumonia (CAP), defined as pneumonia occurring in a previously healthy child within 14 days of symptom onset and requiring hospitalization
- The child's primary caregiver is the mother
- Both mother and child must remain in the hospital for at least 3 days
- Hospitalization due to pneumonia with an expected average stay of 4-5 days, based on disease severity and clinical condition
- Mother must be present as a caregiver throughout the hospital stay
- Voluntary participation with signed informed consent from the parent or legal guardian
You may not qualify if:
- Presence of any chronic disease in addition to pneumonia
- Mother not staying as a caregiver during hospitalization
- Withdrawal of consent by the mother and/or child
- Discharge before 3 days for any reason (e.g., refusal of treatment, early discharge request)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atatürk University Health Sciences Institute and Research Hospital - Department of Pediatrics
Erzurum, Erzurum, 25070, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Türkan KADIROĞLU, Asst Prof
Ataturk University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to participant group assignments to minimize detection bias. Data analysis will also be conducted by an independent researcher who is unaware of group allocations. Due to the nature of the intervention, participants and intervention providers cannot be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 9, 2025
First Posted
August 6, 2025
Study Start
November 1, 2025
Primary Completion
February 1, 2026
Study Completion
May 1, 2026
Last Updated
October 6, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Beginning 6 months after publication and ending 2 years later.
- Access Criteria
- With researchers who submit a methodologically sound proposal and receive approval from the study team.
Individual participant data (IPD) that underlie the results reported in this study (after de-identification) will be shared with qualified researchers. Data will be available for secondary analysis upon request, starting 6 months after publication and for a period of 2 years.